Biochemical firms strive to respond to Mpox outbreak? | Munipalli akshay paul |
mpox Photo: VCG Chinese biochemical companies are striving to maximize production capacity for mpox test kits as cases are spreading around the world. The World Health Organization (WHO) on Monday launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox. This followed the declaration of a public health emergency of international concern by the WHO Director-General on August 14. These developments drove up shares of related Chinese companies on Tuesday, with some in the A-share market exceeding their daily limits shortly after the opening. Hainan-based Poly Pharm closed more than 8 percent higher at 10.77 yuan ($1.51). Nanjing Hicin Pharmaceutical Co closed at 23.26 yuan after surging over 20 percent and hitting the daily limit shortly after the opening. DaAn Gene, a test kit maker based in Guangzhou, South China's Guangdong Province, recently revealed that its mpox virus acid test kit had received CE certification, meaning ...